SG3 Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-770,500
Closed -$5.35M 304
2022
Q2
$6.44M Sell
770,500
-889,500
-54% -$12.4M 0.76% 28
2022
Q1
$37.9M Buy
1,660,000
+1,119,000
+207% +$27.4M 1.07% 8
2021
Q4
$14.9M Buy
541,000
+261,000
+93% +$6.99M 0.3% 53
2021
Q3
$7.8M Buy
280,000
+261,000
+1,374% +$7.4M 0.24% 80
2021
Q2
$557K Buy
19,000
+9,000
+90% +$273K 0.02% 634
2021
Q1
$317K Buy
+10,000
New +$293K 0.01% 878

Other funds holding BHC

SG3 Management's BHC Position: Q3 2022 in Review

SG3 Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 770,500 shares — an estimated $5.35M sold.

SG3 Management first reported a position in BHC in Q1 2021 and held it in 6 quarters. The position peaked at $37.9M in Q1 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • SG3 Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • SG3 Management sold 770,500 Bausch Health shares in Q3 2022, an estimated $5.35M.
  • SG3 Management first reported a position in Bausch Health in Q1 2021 and held it in 6 quarters.
  • SG3 Management's Bausch Health position peaked at $37.9M in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.